Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cool, I missed it to read.
Great update for sure.
Where did you get these products Colsevelam Hydrochloride, Topiramate and Salsalate?
Did they release somewhere? I didn't see on press release or tweet. Did I miss it?
Ohh, I follow it for a long time as I do have a small position.
I had been to their previous office in Corona, CA.
How do I know bro???
Yes, the format is changed for some disclosure information. SHMN has them on it. I think OTCM has changed and added Security information.
I checked with the company and they said minor typo error in the statement of cash flow.
The company filed a new annual report.
Hopefully OTC markets review them tomorrow and bring back to Pink Current.
Just saw changes in the "statement of cash flow", last two lines. Rest is the same.
Go SHMN....
I am so glad to see the updates...
Expect some updates this week....
Agreed ??
Let's see what they share next week as per two last tweets.
Annual they did as per announced tweet and so today's video caught me surprised honestly.
The company has responded by sharing videos to those who continue to demoralize and continue to create false propaganda .
Revenue is still under expectations but I am glad they have maintained the profitability at least.
Go SHMN......
You can directly write, why do I get in???
You said you had conversations with the company..
I agree on the revenues part, but they are moving forward...they addressed the revenue part in past press release..I guess.....
The biggest thing I believe was Shah (Past CEO) was very dynamic and aggressive...look at the past performance prior to 2015 before he had a heart attack. He resigned in August 2015. That's why I said here that we need Shah back with a full backup ..
What I believe, permission gets approval once they keep doing things......
Of course, they have to. As again I have followed the company for several years (almost 10 years) and except for a couple of things, they have performed well and followed through. IMO....
Previously when I had email exchanges with the company, they mentioned San Diego has a lot of additional permissions for pharmaceutical manufacturing and was confirmed by me from an independent contractor.
All should go parallel in my views.
There must be machinery inside the building.
Permission must be for changes inside the warehouse.
FDA does show the listing SOHM. You can visit their website (FDA)
I went that side last week.
I was actually thrilled to see it.
Guessing building change permission, construction permission? Currently it is a warehouse zone..
Good idea, next time probably, I'll do it and share it here.
I think the company has said they'll release the picture etc. As they progress.
I did visit that area and facility does exist. I inquire and some labors said pharmaceutical unit is being build once the various permission etc. is obtained.
AI is at work everywhere, nothing wrong even "Cut and Paste"
Definitely the company is making progress.
I have been following the company and I feel, they need Shah back as during his time, the company was expanding.
Very nice tweet today by the company.
Lately the last three tweets and news are very encouraging.
Go SHMN...
If you read the letter in your link, it was inspected the facility before January 22.
SOHM had tweeted it on April 22.
The letter also says that the company said their CMO went out of business. SOHM is in business, so I was 100% sure it is a different company.
Letter says:
• You use a CMO, (b)(4), to manufacture Hydroquinone USP 4% Skin Bleaching Cream. Your CMO released batch (b)(4) to you on November 16, 2020. You distributed this batch to numerous customers. During the inspection you were unable to provide adequate stability data for your batch and formulation.
• You use a CMO, (b)(4) to manufacture the following products:
o Hydroquinone USP 4% Skin Bleaching Cream
o Sodium Sulfacetamide 10% & Sulfur 5% Cleanser
o Sodium Sulfacetamide 10% and Sulfur 2% Cleanser
o Sodium Sulfacetamide 9.8% and Sulfur 4.8% Cleanser
o Selenium Sulfide 2.25% Shampoo"
I had called the same company and not SOHM.
They said the question raised by the FDA was all for prior batches made from different CMO.
If inquiries or irregularities from SOHM/SOHM' strategic Alliance CMO, their name also should have been in public domain like other company.
Good point.
But I had called the company but they did confirm the products in the FDA letter were not made by SOHM/SOHM's strategic partners. It was different CMO.
I was relieved after listening to them.
Was it supposed to start from the 1st qtr? I didn't follow it.....
Seems like you have inside information based on your confidence.......Lol....
Need some more research at your end about how pharmaceutical distribution works.
What matters is they have continued growth of revenues,profits and legit company. Timely financials matters.....
On their website, PR they have email info@sohm.com in case you want to ask questions. I have received a response.
Very nice performance, continuous growth for last 2/3 years, No change in SS....
Let's go SHMN........
You can ask questions to the company, if you have doubts. They do respond i believe. Majority of the time I send a response they have responded.
Gabapentin is approved ANDA drug and can't be sold without having it.
NDC works differently. NDC appears when any company puts a specific marketing date. Until it doesn't show in the listing.
I am not here to respond to anyone, just like you shared your passive view, I expressed my views. Coin has two sides and without knowing both sides, I don't make any negative comments about individuals or the company. We as outsiders do not know the inside but based on efforts and actions I can imagine that this is a legit company.
Best of luck????
The company was doing good until it's CEO got health trouble in 2015, now since last year they are very active again and have shown continuous growth.
Everyone has a different view and all I care about is, the company is current, yoy profitable and new beginnings.
Pharmaceutical activities take little time. I follow some pharma companies and it is initially always a slow pace and after sometime growth is enormous.
R & D expenses are pointless as some companies use it as part of expenses also being produced as smaller batches of products as trials.
I don't see it is under performing results. Continuous revenue growth and net profit is key and some key products have come in their port folios.
IMO SHMN is on right path and growth whoever says anything.....I follow this company for almost 10 years......
Let's go SHMN........
Last year's results were very encouraging.
So far this year's all actions towards value added activities are continuing.
Internal matters about R & D are operational points.
Whether patent is in India or elsewhere, it shouldn't matter as it is not regular fish oil manufacturing. It is a prescription product in India. SOHM has worldwide rights for distribution means no one has such products in my view. The ingredients list doesn't matter.
IMO all I care about is continuous revenues and updates. SS has not changed for a while.
Based on history of the company, acquisition news also expected. No company appoints new advisory board members if they don't have a plan of actions and strategy.
The pharmaceutical business is very regulated and takes so much time in my view.
It doesn't matter whether a patent is in India or elsewhere as the process is important.
Ingredients don't say anything about the process and uniqueness. If it was made with a simple fish oil process, no country would give the patent.
I think they have more CMO products lately.
Today's product is their new Rx product. I understand that it becomes visible when the marketing starts of the product.